Treatment of facial nerve palsies with laser and endermotherapy: a report of two cases

Panhóca, Vitor Hugo; Nogueira, Marcelo Saito; Bagnato, Vanderlei Salvador

doi:10.1088/1612-202x/abcbf8

Cited by 15 publications

(5 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5 The literature only has seven case reports that use PBM to treat facial paralysis. [6][7][8][9][10] According to a case study by Bernal Rodriguez et al, 2020, a facial paralysis that had been unresponsive for eight years may be effectively treated using a dual-wavelength (660 nm and 808 nm) photobiomodulation procedure that involved twenty-four consecutive PBM therapy sessions. Three distinct cases of severe, chronic facial palsy were treated in a study by Zarkovic et al, and facial paralysis recovery was achieved by using 34 PBM sessions spaced five months apart, targeting deep-seated tissue with 1064 nm near infrared (NIR).…”

Section: Discussionmentioning

confidence: 99%

A Case Study Photobiomodulation As The Solution For Bell's Palsy

2024

IJFMR

View full text Add to dashboard Cite

Often affecting one side, Bell's palsy, also known as "acute facial palsy of unknown cause," is a common cranial neuropathy that results in abrupt, complete paralysis or face muscle paresis. Over the period of 48 hours, the condition may get worse. It is brought on by damage or inflammation to the 7th cranial nerve, the face nerve, or any of its branches along its course, primarily in the bony canal. This results in dysfunction of the facial nerve. It is equally prevalent in both sexes and has no age restriction, however as people age, so does the incidence. A increased risk is associated with diabetes, hypertension, obesity, pregnancy, and upper respiratory tract infections. It is mainly believed to be idiopathic and is diagnosed by ruling out other potential causes. Bell's palsy sufferers and their family may experience severe consequences, including psychological and physical problems. Therefore, a timely cause determination and early diagnosis are essential to efficient treatment. However, the exact etiology of Bell's palsy remains unknown, which affects the course of treatment. To adopt a customized therapy strategy, however, a comprehensive examination and a comprehensive history are necessary to determine the likely cause and risk factors. Most patients heal on their own in less than three weeks, even without treatment. Still, there's always a chance of lingering paresis after therapy or recovery.

show abstract

Section: Discussionmentioning

confidence: 99%

A Case Study Photobiomodulation As The Solution For Bell's Palsy

2024

IJFMR

View full text Add to dashboard Cite

show abstract

“…There are only four case reports in the literature utilizing PBM in the management of facial paralysis [1,9,11,48]. A case report conducted by Bernal Rodriguez et al, 2020 [1] concluded that utilizing a protocol of dual-wavelength (660 nm and 808 nm) PBM with 24 consecutive PBM treatment sessions was effective in treating a facial paralysis of 8 years.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of 1064 nm Photobiomodulation Dosimetry Delivered with a Collimated Flat-Top Handpiece in the Management of Peripheral Facial Paralysis in Patients Unresponsive to Standard Treatment Care: A Case Series

Zarkovic Gjurin,

Pang,

Vrčkovnik

et al. 2023

JCM

View full text Add to dashboard Cite

Peripheral facial paralysis (PFP) is a common condition where oxidative stress (OS) is involved in the pathophysiology of facial paralysis, inhibiting peripheral nerve regeneration, which can be featured in Bell’s palsy, Ramsay Hunt syndrome and Lyme disease. The current standard care treatments lack consensus and clear guidelines. Hence, the utilization of the antioxidant immunomodulator photobiomodulation (PBM) can optimize clinical outcomes in patients who are unresponsive to standard care treatments. Our study describes three unique cases of chronic PFP of various origins that were unresponsive to standard care treatments, but achieved a significant and complete recovery of facial paralysis following PBM therapy. Case presentations: Case #1: a 30-year-old male who presented with a history of 12 years of left-side facial paralysis and tingling as a result of Bell’s palsy, where all the standard care treatments failed to restore the facial muscles’ paralysis. Eleven trigger and affected points were irradiated with 1064 nm with an irradiance of ~0.5 W/cm2 delivered with a collimated prototype flat-top (6 cm2) in a pulsed mode, with a 100 µs pulse duration at a frequency of 10 Hz for 60 s (s) per point. Each point received a fluence of 30 J/cm2 according to the following treatment protocol: three times a week for the first three months, then twice a week for another three weeks, and finally once a week for the following three months. The results showed an improvement in facial muscles’ functionality (FMF) by week two, whereas significant improvement was observed after 11 weeks of PBM, after which the House–Brackmann grading scale (HBGS) of facial nerve palsy dropped to 8 from 13 prior to the treatment. Six months after PBM commencement, electromyography (EMG) showed sustainability of the FMF. Case #2: A five-year-old female who presented with a 6-month history of severe facial paralysis due to Lyme disease. The same PBM parameters were utilized, but the treatment protocol was as follows: three times a week for one month (12 consecutive treatment sessions), then the patient received seven more sessions twice a week. During the same time period, the physiotherapy of the face muscles was also delivered intensively twice a week (10 consecutive treatments in five weeks). Significant improvements in FMF and sustainability over a 6-month follow-up were observed. Case #3: A 52-year-old male who presented with severe facial palsy (Grade 6 on HBGS) and was diagnosed with Ramsay Hunt syndrome. The same laser parameters were employed, but the treatment protocol was as follows: three times a week for three weeks, then reduced to twice a week for another three weeks, then weekly for the next three months. By week 12, the patient showed a significant FMF improvement, and by week 20, complete FMF had been restored. Our results, for the first time, showed pulsed 1064 nm PBM delivered with a flat-top handpiece protocol is a valid and its treatment protocol modified, depending on the origin and severity of the condition, which is fundamental in optimizing facial paralysis recovery and alleviating neurological symptoms. Further extensive studies with large data are warranted to validate our PBM dosimetry and treatment protocols.

show abstract

“…VT can be applied to stimulate lymphatic drainage and sensorimotor stimulation. It can also provide myofascial release after therapy, as it is a type of massage [47,48]. VT is a non-invasive technique of mechanical massage that consists of applying negative pressure by sucking the skin and subcutaneous tissue.…”

Section: Vt Combined With Laser Therapymentioning

confidence: 99%

“…VT is a non-invasive technique of mechanical massage that consists of applying negative pressure by sucking the skin and subcutaneous tissue. Moreover, VT has been used in the treatment to improve circulation and oxygenation of the connective tissue, being widely applied in the treatment of cellulite with an aesthetic effect and redistributing the subcutaneous adipose tissue [47].…”

Section: Vt Combined With Laser Therapymentioning

confidence: 99%

Perspectives on photobiomodulation and combined light-based therapies for rehabilitation of patients after COVID-19 recovery

Dias¹,

Blanco²,

Faria³

et al. 2022

Laser Phys. Lett.

View full text Add to dashboard Cite

The post-COVID-19 condition or ‘long COVID’ is a clinical and scientific challenge for society. In this regard, patients after COVID-19 recovery show a vast range of sequels including muscular, articular lesions, neurological, dermatological, and pulmonary issues. These clinical consequences are issues in the present and for the future. In this case, rehabilitation therapies based on photobiomodulation and combined therapies arise as excellent tools to solve it. Herein, we describe and discuss the perspectives on the use of light-based therapies such as photobiomodulation, photodynamic therapy and combined vacuum and laser therapy for rehabilitation of patients who present some sequelae of the COVID-19 infection. We did not intend to produce a comprehensive review; instead we highlight the most important and clinical protocols against these sequels. Moreover, the principles and mechanism of action of each light-based technique proposed were reported and discussed.

show abstract

Treatment of facial nerve palsies with laser and endermotherapy: a report of two cases

Cited by 15 publications

References 14 publications

A Case Study Photobiomodulation As The Solution For Bell's Palsy

A Case Study Photobiomodulation As The Solution For Bell's Palsy

Efficacy of 1064 nm Photobiomodulation Dosimetry Delivered with a Collimated Flat-Top Handpiece in the Management of Peripheral Facial Paralysis in Patients Unresponsive to Standard Treatment Care: A Case Series

Perspectives on photobiomodulation and combined light-based therapies for rehabilitation of patients after COVID-19 recovery

Contact Info

Product

Resources

About